Celetrix Biotechnologies CTX-1500A LE Cell Electroporator 20-200μl Capacity
Used and in working order based on our intake inspection. It has not been through full performance testing, so please confirm it suits your application. Normal signs of prior use.
Celetrix Biotechnologies
Questions about this item? Call us (760) 560-0013
Details
-
CategoryMolecular Biology
-
Dimension10.0in x 11.0in x 5.0in
-
Serial734210012394
-
Shipping TypeFedEx Ground
-
Voltage / Hertz100-240V / 50Hz/60Hz
Description
The Celetrix Biotechnologies CTX-1500A LE Cell Electroporator is designed for high-efficiency, low-toxicity electroporation processes. This unit supports 20μl, 100μl, 120μl, and 200μl electroporation tubes, offering flexibility in your applications. Although the unit exhibits minor cosmetic wear, including a small scratch on the right side, it powers on and performs basic self-tests successfully. However, it is unable to be fully tested due to the absence of the Electroporation kit (20μl-200μl). Manufactured to operate on 100-240V with 50Hz/60Hz for versatile use in various lab settings. Please refer to the photos for more details.
Key Features
- Electroporator for 20μl-200μl tubes
- High-efficiency
- Low-toxicity
- Supports 100-240V
- 50Hz/60Hz Operation
Specifications
- Voltage: 100-240V
- Hertz: 50Hz/60Hz
- Compatible with 20μl, 100μl, 120μl, 200μl tubes
- Minor cosmetic wear
Weight
Imperial: 12.0 Pounds
Metric: 5.44 Kilograms
Shipping Dimensions
Imperial: 12.0 lb x 13.2 lb x 6.0 lb
Metric: 30.48 cm x 33.53 cm x 15.24 cm
Harmonized Code
903180
Harmonized Code Details
Harmonized Code 903180 - Instruments, appliances and machines for measuring or checking, n.e.s. This code is used for specialized scientific equipment, including electrophoresis systems.
Product Enquiry
Have a question about this product? Send us your enquiry and our sales team will get back to you shortly.
Inform me when available
This item has sold. Leave your details and we will get in touch when a similar model becomes available.
Comments 0
There are currently no public comments.